Nonalcoholic Steatohepatitis Is Becoming a Top Indication for Liver Transplantation Worldwide
Mehmet Sayiner, Zobair M. Younossi – 25 November 2018
Letter to the Editor: Patient‐Reported Outcomes for Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: Rationale for Expanded Use
Patrizia Carrieri, Martin Duracinsky, Fabienne Marcellin, Jeffrey V. Lazarus – 25 November 2018
Sarcopenia and Frailty in the Prognosis of Patients on the Liver Transplant Waiting List
Maryam Ebadi, Aldo J. Montano‐Loza – 25 November 2018
Diagnosis and Treatment of Alcohol Use Disorder in Patients With End‐Stage Alcoholic Liver Disease
Fabio Caputo, Marco Domenicali, Mauro Bernardi – 24 November 2018 – Between 14%‐30% of the world’s population is affected by alcohol use disorder (AUD), and excessive alcohol consumption represents the most common cause of liver disease in the western world. The clinical picture of alcoholic end‐stage liver disease is rendered extremely complex, as manifestations such as alcohol withdrawal syndrome, craving and physical dependence, as well as extrahepatic alcohol‐related diseases merge with the complications of advanced cirrhosis.
Diagnosis and Treatment of Alcohol Use Disorder in Patients With End‐Stage Alcoholic Liver Disease
Fabio Caputo, Marco Domenicali, Mauro Bernardi – 24 November 2018 – Between 14%‐30% of the world’s population is affected by alcohol use disorder (AUD), and excessive alcohol consumption represents the most common cause of liver disease in the western world. The clinical picture of alcoholic end‐stage liver disease is rendered extremely complex, as manifestations such as alcohol withdrawal syndrome, craving and physical dependence, as well as extrahepatic alcohol‐related diseases merge with the complications of advanced cirrhosis.
Reply
Jesús Quintero, Cristina Molera, Javier Juamperez, Susanna Redecillas, Silvia Meavilla, Raquel Nuñez, Camila García‐Volpe, Mireia del Toro, Ángels Garcia‐Cazorla, Juan Ortega, Óscar Segarra, Javier Martin de Carpi, Itxarone Bilbao, Ramon Charco – 24 November 2018
Auxiliary Partial Orthotopic Liver Transplantation for Noncirrhotic Metabolic Liver Disease: Reigniting Interest in an Old but New Technique
Mureo Kasahara, Seisuke Sakamoto, Reiko Horikawa, Akinari Fukuda – 24 November 2018
Sexual Dysfunction and Sex Hormone Abnormalities in Patients With Cirrhosis: Review of Pathogenesis and Management
Shuet Fong Neong, Emma O. Billington, Stephen E. Congly – 23 November 2018 – Healthy sexual function is important to maintain a good quality of life but is frequently impaired in patients with cirrhosis. The degree of sexual dysfunction appears to be linked with the degree of hepatic dysfunction. In men, sexual dysfunction can be related to the hyperestrogenism of portal hypertension and/or to decreased testosterone resulting from testicular dysfunction.
New Strategies for the Management of Decompensated Cirrosis: Long‐Term Albumin Administration for Everyone?
Elsa Solà, Cristina Solé, Pere Ginès – 23 November 2018
Sexual Dysfunction and Sex Hormone Abnormalities in Patients With Cirrhosis: Review of Pathogenesis and Management
Shuet Fong Neong, Emma O. Billington, Stephen E. Congly – 23 November 2018 – Healthy sexual function is important to maintain a good quality of life but is frequently impaired in patients with cirrhosis. The degree of sexual dysfunction appears to be linked with the degree of hepatic dysfunction. In men, sexual dysfunction can be related to the hyperestrogenism of portal hypertension and/or to decreased testosterone resulting from testicular dysfunction.